Literature DB >> 2033251

Release of the cytokines colony-stimulating factor-1, granulocyte-macrophage colony-stimulating factor, and IL-6 by cloned murine vascular smooth muscle cells.

J W Schrader1, C Moyer, H J Ziltener, C L Reinisch.   

Abstract

Vascular smooth muscle cells were cultured from the mesenteric arteries of MRL lpr/lpr, MRL +/+, CBA/J, or C3H/HeJ mice and evaluated for their ability to synthesize a range of cytokines. Vascular smooth muscle cells of MRL +/+, MRL lpr/lpr, and CBA/J origin released biologically significant amounts of CSF-1 and IL-6 and relatively low but detectable amounts of granulocyte macrophage-CSF (GM-CSF) but not IL-2, IL-3, or IL-4. Vascular smooth muscle cells of C3H/HeJ origin produced lower amounts of CSF-1 and IL-6, and GM-CSF was barely detectable. Production of these cytokines did not require the exogenous growth factors present in FCS and occurred, although at lower levels, in serum-free medium supplemented with insulin, transferrin, and albumin. Cloned lines of MRL +/+ vascular smooth muscle cells, with electron microscopic and immunochemical properties of vascular smooth muscle cells, produced CSF-1, IL-6, and GM-CSF, establishing that vascular smooth muscle cells were a direct source of CSF-1, IL-6, and GM-CSF. These observations highlight the need for experiments to directly address the question of whether vascular smooth muscle cells constitutively produce these cytokines under physiologic conditions in vivo and suggest that vascular smooth muscle cells may participate actively in inflammation by releasing cytokines that are active on lympho-hemopoietic and other cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033251

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Control of vascular smooth-muscle cell growth by macrophage-colony-stimulating factor.

Authors:  T Herembert; J Gogusev; D L Zhu; T B Drueke; P Marche
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 2.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

3.  Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins.

Authors:  S Hou; X Y Mo; L Hyland; P C Doherty
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

4.  Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1).

Authors:  J A Hamilton; R Byrne; W Jessup; V Kanagasundaram; G Whitty
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

5.  Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.

Authors:  S K Clinton; R Underwood; L Hayes; M L Sherman; D W Kufe; P Libby
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

6.  Brain microvascular smooth muscle and endothelial cells produce granulocyte macrophage colony-stimulating factor and support colony formation of granulocyte-macrophage-like cells.

Authors:  M N Hart; Z Fabry; L Love-Homan; J Keiner; K L Sadewasser; S A Moore
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

7.  Multiple Signaling Molecules are Involved in Expression of CCL2 and IL-1β in Response to FSL-1, a Toll-Like Receptor 6 Agonist, in Macrophages.

Authors:  Keunsoo Won; Sun-Mi Kim; Sae-A Lee; Byung-Yong Rhim; Seong-Kug Eo; Koanhoi Kim
Journal:  Korean J Physiol Pharmacol       Date:  2012-12-10       Impact factor: 2.016

8.  Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease.

Authors:  Samaneh Enayati; Soroush Seifirad; Parvin Amiri; Milad Abolhalaj; Mahsa Mohammad-Amoli
Journal:  ARYA Atheroscler       Date:  2015-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.